Subscribe to our RSS feed

The Latest Arts and Entertainment Stories

  •  Gaga inspires a pop culture romp
  • Thirteen reasons why I made ‘The Key’
  • Six months of POZ-TO
  • Top ten
  • Judging the judging

Revolving Door

May19

The first anal condom begins clinical trial in Boston

Sunday, 19 May 2013 Written by // Guest Authors - Revolving Door Categories // Health, Sexual Health, Revolving Door, Guest Authors

Insert and play. New fangled condoms in development place the bottom on top.

The first anal condom begins clinical trial in Boston

ORIGAMI Condoms, based in Los Angeles, CA, has been in development of the world’s next generation of condoms. The company’s unique silicone condom designs include the first condom designed and clinically tested for anal intercourse, the ORIGAMI Anal Condom. A Phase 1 Clinical Trial is underway in collaboration with researchers at The Fenway Institute of Boston. 

Surprising to most consumers, especially to gay men, no condom has ever been safety tested for anal sex usage, nor has it been reviewed or approved for such by the FDA.

The near universal dissatisfaction with the old, rolled latex condom has marked the history of condom use since its creation, and consumers are eager for more pleasurable, less compromising options. Things that are worn need to be design-specific to human anatomy. Hats are designed to wear on the head, shoes designed for feet, and likewise a condom for anal sex needs to be designed for compatibility with the rectum. The designers at ORIGAMI Condoms believe that the time for a new idea is long overdue.

The rolled latex condom has not had a significant structural design change since it was first marketed around 1918. 

The ORIGAMI Anal Condom is the first design initiative to propose a condom specifically for anal sex. It is an inserted condom that is internally fitted into the rectum for receptive anal intercourse. This means the ‘top’ partner needs no condom. The innovation reduces potential irritation for the receptive partner and simultaneously optimizes sensation for the penetrating partner. It is intended to be easily inserted with one finger and it could be put in place hours before intercourse. This new idea eliminates the distraction with intimacy that is often associated with unrolling a male condom onto the penis.  

The condom industry, now dominated by four major players, has not successfully leveraged new technologies for typical product design evolution. Condoms are still made the same way with the same type of dip molding equipment they started with following the industrial revolution. The issue is that men have never liked this form of protection but there was never an alternate choice available, until now. A paradigm shift from 'protection' to 'pleasure' will take some time, although the ORIGAMI Condom people are quite advanced with their developments. 

The Bill & Melinda Gates Foundation noted that “Origami Condoms provides an excellent example of a private enterprise focused on new condom design to promote consistent use by emphasizing the sexual experience. The idea of a condom that men [and women] would prefer to no condom is a revolutionary idea, but we know more today about sexual function than at any time in the past, and advances in relevant disciplines such as neuroscience, vascular biology, urology, reproductive biology, materials science, and other fields can contribute to new and unconventional approaches.” 

"What if we could develop a condom that would provide all the benefit of our current versions, without the drawbacks? Even better, what if we could develop one that was preferred to no condom? The idea of a condom that men would prefer to no condom is a revolutionary idea, but we know more today about sexual function than at any time in the past, and advances in relevant disciplines such as neuroscience, vascular biology, urology, reproductive biology, materials science, and other fields can contribute to new and unconventional approaches." 

The US clinical trial for the ORIGAMI Anal Condom was funded by the National Institutes of Health. The new type of condom is expected to reach the market following FDA review sometime in mid-2015. 

The Bill & Melinda Gates Foundation has decided to launch a competition for the eagerly anticipated, next generation of condoms. The winner of their $100,000 Grand Challenges Explorations may redefine how people all over the world will have sex in the very near future. The Gates Foundation is also offering the winners of this design challenge the opportunity for a subsequent, Phase II award of $1,000,000 to complete their product development and bring it to

May18

Infectiousness

Saturday, 18 May 2013 Categories // Gay Men, Health, Research, International , Sexual Health, Population Specific , Revolving Door, Guest Authors

Aidsmap.com reports about 10% of gay men taking antiretroviral treatment have low levels of HIV detectable in their semen, according to new research. Whether or not this level of HIV in semen is associated with transmission is unknown.

Infectiousness

About 10% of gay men taking antiretroviral treatment have low levels of HIV detectable in their semen, according to new research. 

In the study, a low but detectable viral load (between 50 and 500 copies/ml) was associated with the presence of HIV in semen.

There is currently a lot of discussion about the effect of HIV treatment on infectiousness and the use of HIV treatment as prevention. Research conducted in heterosexual couples has shown that antiretroviral therapy that reduces viral load in the blood to undetectable levels (below 50 copies/ml) reduces the risk of sexual transmission by 96%. (PositiveLite.com editors note: the research to which this refers - HPTN 052  - measured the impact of early treatment, not undetectable viiral load, two entirely different concepts..  We have questioned aidsmap.com about the accuracy of their statement.)

But there have been rare case reports of HIV transmissions in the presence of an undetectable viral load.

Untreated bacterial sexually transmitted infections (STIs) such as chlamydia and gonorrhoea may cause viral load to increase in genital fluids, even if a person is taking effective antiretroviral treatment.

Doctors in the United States wanted to see if infection with human herpes viruses also had an impact on viral load in genital fluids.

They monitored blood and semen samples taken from 114 gay men. All were taking HIV treatment and had a blood viral load below 500 copies/ml (88% had a viral load below 50 copies/ml).

HIV was detected in the semen of 10% of the men. The average viral load in semen was low – 126 copies/ml. Whether or not this level of HIV in semen is associated with transmission is unknown.

Detection of HIV in semen was associated with the presence of two viruses of the herpes family – high semen levels of CMV (cytomegalovirus) and detectable EBV (Epstein Barr virus) in semen.

“The association between isolated HIV shedding and high-level CMV replication and EBV replication in the genital tract suggests that the presence of these viruses could play a role in HIV transmission…these findings have important implications for the development of strategies to reduce HIV transmission,” comment the researchers.

They also found that 36% of study participants with a detectable viral load were shedding HIV in semen compared to 6% of participants with an undetectable viral load.

A urethral bacterial STI was diagnosed in 4% of men, but these untreated infections were not associated with the presence of HIV in semen.

For more detailed information on HIV transmission, visit our online resource HIV transmission and testing.

This article originally appeared in aidsmap news, May 2013. Read the full article here.

 

May15

PrEP – What have I done to deserve this? (Part 3 of 3)

Wednesday, 15 May 2013 Written by // Guest Authors - Revolving Door Categories // As Prevention , Gay Men, Health, Treatment, Opinion Pieces, Population Specific , Revolving Door, Guest Authors

Guest Marc-André LeBlanc is a negative gay man who is taking an antiretroviral drug, Truvada, as pre exposure prophylaxis (PrEP). In the last of three episodes he recounts what it’s like to be taking the pills daily – and how he feels about that.

PrEP – What have I done to deserve this? (Part 3 of 3)

“I’ve been told that I can look forward to a tremendous reduction in stress and anxiety about seroconverting. I look forward to that. We’ll see. “ 

On April 5, 2013 I took my first dose of Truvada as pre-exposure prophylaxis (PrEP). I won’t deny it. I’ve been feeling very conflicted about starting PrEP.  

Why do I have access to Truvada when the majority of people who need antiretroviral medication to stay alive don’t have access? I got my hands on this bottle relatively easily. The social injustice is not lost on me. I don’t have relatively easy access to this medication because I deserve it more than anyone else.

So what HAVE I done to deserve access to PrEP? Well, a lot of it is sheer luck, actually.

    Nearly every time I see the news, I am amazed at how lucky I am. I was born in Canada. Talk about winning the lottery. Out of 7 billion people, I am one of only 34 million people living in Canada. Trust me, it’s a great place to live!

    I’ve been working in HIV for 20 years, including the last 10 years focussed on tracking biomedical HIV prevention research. This provides me with ongoing access to the latest information.

    I make a good living. I can access healthcare relatively easily and generally for free or at a cost that has little impact on my standard of living.

    I have a doctor. He’s young (My age. That’s young. Shut up.), gay, and sees a lot of people living with HIV in his practice. So talking to him about my sex life and about PrEP was not difficult. He keeps up to date on research. After a good discussion, he agreed to prescribe PrEP.

    Not only do I live in Canada, but I live in Québec, the only province to have a universal public drug plan. As long as the drugs my doctor prescribes are on the provincial drug formulary, I am covered for most of the cost. I pay $500 into the drug plan annually, and PrEP will cost me less than $1,000/year on top of that. And if I ever need other drugs for any reason, I will not pay for them. Because $992/year ($82.66/month to be precise) is the most I would have to pay for all my drugs combined.

I’m not trying to be disingenuous. I know that beyond being lucky and privileged, I have access to PrEP because I’ve taken some very concrete steps as well. I did lots of introspection. I tried to reduce my risk as much as possible through other means. I did a lot of research. I actively sought out access. I make sure I’m very diligent about taking my pills.

I always have been very diligent about that. I take all my antibiotics when I need them. I take vitamins daily. When I was on antidepressants, I never missed a dose in 1.5 years. I follow advice from medical professionals to the letter. Case in point: I’ve needed physiotherapy twice. Both times, the conversation during my second visit went something like this:

Physiotherapist: Wow, you’re made remarkable progress in one week. I’ve never seen anyone progress so quickly with this type of injury. Which exercises did you do?

Me: All of them, like you showed me.

PT: You did ALL the exercise I gave you?! How often?

Me: Every day, like you told me.

PT: You did ALL your exercise EVERY day?! How many times a day?

Me: Twice, like you told me.

PT: You did ALL your exercises, EVERY day, TWICE a day?! I’ve never seen this in all my years of practice! No wonder you’re doing so well!

*SLAP* You’re at risk of HIV!

I might make jokes, but I don’t take this lightly.

Every morning when I wake up it’s the first thing I think about. That might stop after a while. But two weeks into taking PrEP, it’s the same thing. I wake up, and as I ponder about whether I want to go back to sleep again for a little longer, I can’t do it. I immediately think: when I get up I have to take my Truvada pill. Because I’m at risk of HIV.

Each and every time I open the cupboard and grab the bottle, I think: how is it possible that I am so lucky to have such easy access to this medication when millions of people who need it to stay alive don’t have access?

Who needs a coffee? I get a slap in my face every morning. Two of them in fact.

*SLAP* You’re at risk of HIV and STIs!

*SLAP* You’re one of the lucky few who has access to this medication and to this prevention option!

I’ve been told that I can look forward to a tremendous reduction in stress and anxiety about seroconverting. I look forward to that. We’ll see. I’m not there yet by any stretch. But at least I get some measure of comfort from knowing that I’m putting chances on my side by reducing my risk as much as I can in my current situation. Doing my best to stay healthy seems like the right thing to do to honour those who don’t have access to this drug.

About the author: Marc-André LeBlanc has worked in the community-based HIV/AIDS movement for 20 years.He does community engagement, capacity-building and policy work related to biomedical HIV prevention research, both in Canada and globally. He is a co-founder of International Rectal Microbicide Advocates (IRMA), serves as secretary on their steering committee, has authored two reports on the global state of rectal microbicide efforts, and leads IRMA’s global efforts to ensure the safety of sexual lubricants. Marc-André loves movies. He got a film studies degree while working full-time, just for the sheer fun of it. He is now leading advocacy efforts to get ice cream and popcorn recognised as new basic food groups in Canada’s Food Guide

This article originally appeared on My PrEP Experience here

May15

Candlelight memorial in British Columbia

Wednesday, 15 May 2013 Written by // What's Up Categories // Community Events, Events, Revolving Door, Events, Guest Authors

Vancouver International AIDS Candlelight Memorial on Sunday May 19, 2013 beginning at 7:30pm in Alexandra Park at the Gazebo/Band Stand.

Candlelight memorial in British Columbia

From Bradford McIntyre of PositivelyPositive.ca  comes this notice of Vanocover’s up coming candlelight memorial . . 

“We have a stellar cast of speakers and performers this year to celebrate and perform a musical tribute to people affected and infected by HIV and to all of those friends and family we have lost to HIV/AIDS.

This year marks AIDS Vancouver's 30th Anniversary. This year also marks the AIDS Candlelight Memorial’s 30th Anniversary.

AIDS Vancouver is the host of the 30th Vancouver International AIDS Candlelight Memorial.

In this special year, this event is a musical tribute.

In Solidarity: A Musical Tribute to People Infected and Affected by HIV and those we have lost to AIDS.

As vice-chair on AIDS Vancouver’s board of directors, I have spent the past three months organizing the 30th Vancouver International AIDS Candlelight Memorial, planning the program and inviting this year’s participants. I will be master of ceremonies (MC) for the event. Learn more about it here.

The Program:

The 30th Vancouver International AIDS Candlelight Memorial

In Solidarity: A Musical Tribute to People Infected and Affected by HIV and those we have lost to AIDS.

May 19th 2013 at 7:30 PM in Alexandra Park, 1755 Beach Avenue, at Bidwell

Master of Ceremonies: Bradford McIntyre

Speakers and Performers

Chief Bill Williams

Bob Baker & The Eagle Song Dancers

Vancouver Men's Chorus

Leora Cashe

Jess Cullen

PALS Chorus

Andrew Hiscox

James Johnstone

Ending with the Lighting of the Candles "

May14

Gay men and sex

Tuesday, 14 May 2013 Written by // Guest Authors - Revolving Door Categories // Gay Men, Health, Research, Sexual Health, International , Population Specific , Sex and Sexuality , Revolving Door, Guest Authors

Aidsmap.com reports consistent decline in partner numbers in US gay men in last decade, but no change in condom use

Gay men and sex

This article by Gus Cairns first appeared on aidsmap.com here.  

Data from two national sex surveys in the United States show that gay and bisexual men (men who have sex with men, MSM) reported significantly fewer sexual partners in the previous year in a survey conducted between 2006 and 2010 than they did in one conducted in 2002. This decline was consistent across most ethnicities and age groups, but was particularly marked, and statistically significant, in younger men aged under 24.

In contrast, the proportion who reported having condomless anal sex at least once in the previous year did not change between surveys. In the minority of men who also had sex with women, condom use fell markedly, but on the other hand the proportion of MSM who also had sex with women fell too.  

The proportion of men who tested for HIV or for sexually transmitted infections (STIs) in the last year did not change, although the proportion who had never tested for HIV fell.

The survey

The data come from the last two National Surveys of Family Growth (NSFGs). The NSFG is a survey of 15 to 44-year-olds; participants are contacted at random by phone but due to lower contact/response rates, people under 24, black people and Hispanic people are ‘oversampled’, i.e. a higher proportion are initially contacted than are in the general population.

NSFGs used to be conducted every three to seven years, but in 2006 a decision was taken to conduct interviews (by voice-assisted automated computer interview) continuously. This study therefore compared figures from interviews conducted in 2002 with ones conducted in 2006 to 2010.

NSFG interviewed 4928 and 10403 men in 2002 and 2006 to 2010, respectively. Of these, 197 and 272 reported having a male sexual partner in the last year – 2.7 and 2.1% respectively (this difference was not statistically significant, p = 0.1).

The results

The mean number of male sexual partners MSM reported in the previous year fell significantly from 2.9 to 2.3 between the two surveys (p = 0.035) and was more marked in men under 24 years old (mean 2.9 to 2.1 partners, p = 0.027). The number of partners also fell in men aged 35 to 44 from 3.0 to 2.2, though this was not quite statistically significant (p = 0.07).

The fall in the number of partners was statistically significant in men with incomes under 150% of the US federal poverty level (3.0 to 2.1) and in men living in suburban metropolitan areas (3.2 to 2.1) but not in city-centre areas (2.6 in both surveys). There were declines in partner numbers in white (3.0 to 2.5) and black (2.4 to 1.9) men, though these did not reach statistical significance. In general though, there was a consistent picture of fewer partners among most groups.

There were no changes in condom use for anal sex. In 2002, 57% of men had not used a condom the last time they had sex and in 2006 to 2010 the proportion was 58%. In the minority of men who also had sex with women, the proportion who had not used a condom the last time they had vaginal sex was 46% in 2002 but had become 67% by 2006 tp 2010, and this difference was statistically significant (p = 0.04). However, the proportion of MSM who had had female partners also decreased from 38 to 25% (p = 0.03).

One other notable difference was that fewer men reported transactional sex (sex for money or drugs) in the last year (down from 15 to 3%) and fewer men said they had injected drugs or had had sex with someone who had injected drugs (from 12 to 5%).

HIV and STI testing in the last year did not increase. In 2002 and 2006 to 2010, 41% of men said they had had an HIV test in the last year and in the case of STI check-ups 38% reported having one in 2002 and 39% in 2006 to 2010. The proportion of men who had never had an HIV test, however, fell from 25 to 15%.

Conclusions and comments

The researchers comment on the fact that HIV prevalence and the incidence of STIs increased in gay men during a period when numbers of partners and some other sexual risk behaviours were falling. They note that there have been previous studies in Seattle and Peru where STI incidence and/or HIV diagnoses have remained high even though sexual risk indicators in gay men have fallen. Studies of young black gay men in the US, including one recently presented at the 20th Conference on Retroviruses and Opportunistic Infections (CROI), have consistently shown that they tend to have fewer partners despite considerably higher HIV incidence.

The researchers speculate that this may be due to ‘network factors’: factors about partners that are not captured by the individual risk behaviour focus of most studies. For instance, some studies have found that black gay men tend to restrict sex to partners of their own ethnicity and are also more likely to have sex with men a number of years older or younger than themselves. Both of these would tend to concentrate HIV infection within the black gay community.  

Whether these are the main drivers of US black men’s greater vulnerability to HIV infection, another interesting aspect of this study is that gay men appear to have taken steps that could reduce their HIV risk by using a method that has received little emphasis in HIV prevention programmes for gay men – reducing their number of partners – while not increasing condom use, which has received the most emphasis.

Reference

Leichliter JS et al. Temporal trends in sexual behaviour among men who have sex with men in the United States, 2002 to 2006-10. J Acquir Immun Defic Syndr, early online publication, DOI: 10.1097/QAI.0b013e31828e0cfc, 2013. 

May13

Thirteen reasons why I made ‘The Key’

Monday, 13 May 2013 Written by // Guest Authors - Revolving Door Categories // As Prevention , Arts and Entertainment, Movies, Gay Men, Health, Music, Treatment, Opinion Pieces, Population Specific , Sex and Sexuality , Revolving Door, Guest Authors

Guest Magpie Suddenly made a music video supporting negative guys taking PrEP to prevent HIV, with a powerful message about stigma: “Taking Truvada as PrEP doesn’t make someone a whore.” Here is the video and Magpie’s explanation of why he made it.

Thirteen reasons why I made ‘The Key’

1. 

Because I was possessed by a demon. 

And because I was pregnant for 22 months with its child. 

That’s why I made ‘THE KEY.’ 

2. 

Last week, a young friend of mine started PrEP.  

He's 24 and heard about it online, has good health insurance, so has it covered.  He told me the news as we were catching up after a recent sex party we were at together. 

His news shocked me. And not because he started PrEP. 

The shocking part was that none of his peers believed him when he told them about taking the pills to prevent HIV. 

They thought he was lying. 

And that’s why I made ‘THE KEY.’ 

3. 

One gay man possessed by a demon and pregnant for 22 months means there’s likely to be others. 

And any Queen worth his weight in taffeta and sequins knows our sacred heritage is a river of blood. 

That’s why I made ‘THE KEY.’  

4. 

Feels like no one is hearing about PrEP. Especially gay boys in Seattle.  

Most are still surprised to hear me tell of a pill that could prevent an exposure to HIV leading to a lifelong infection. 

After 30+ years of exposures leading to infections, you’d think everyone who has stuck around this long in the fight against HIV would be simply gushing about PrEP, overly ecstatic about a new way for these pills that already save millions of lives to save a few thousand more. 

You’d think we’d all be yawping from the roofs of the world about this possibility. 

Yet every day I meet gay guys who have never heard that they could take a pill a day and keep the HIV away. 

That’s a FUCKING EPIC FAILURE in my book. 

That’s why I made ‘THE KEY.’ 

5. 

My young friend’s friends think he’s HIV-positive.  All because he now has HIV meds in his possession. 

Before you start your tsk-tsk-tsking, remember that a bottle of Truvada kept in a medicine cabinet attracts HIV stigma like a lightning rod. 

Both Truvada and a lightning rod protect, but only Truvada has 2 really toxic side effects that make AIDS Healthcare Foundation hit the streets with pitchforks and press releases: 

1) It can cause an African woman to be beaten in front of her neighbors if found in her possession. 

2) It almost always leads to judgments and rejections for the rest of your living days. 

And that’s why I made ‘THE KEY.’ 

6. 

We gotta work through this crap. 

We are gay men rejecting gay men living with HIV.  

And we do it thinking we just dodged a bullet, proud to have drummed away the damaged goods. We believe it keeps us safe. 

We ALL do it. Or have done it. We do it every day. Every hour.

Every gay guy knows this crap we throw at poz guys. 

This is the sour truth that makes most gay guys afraid to test.

They know firsthand the crap we throw at poz guys, the judgments and rejections for the rest of your living days. 

And—suddenly--they realize they might become one of ‘THEM.’ 

Now this crap has become a wall between us and the most powerful prevention tool we have to this day discovered. 

That’s why I made  ‘THE KEY.’ 

7. 

PrEP is the first thing in 30+ years proven to lower rates of infection for the gays –-by 42% --and that was when it was used imperfectly by gay boys, and before it was known to work. 

42% doesn’t sound like a lot. But do the math. 

Look up on Google the number of gay men/trans women newly diagnosed with HIV in your favorite city. 

Multiply that number by .42. 

Now stare at that number, and you’ll get an idea of how many people we might have kept from a lifetime of daily pill-taking -- if we wanted to. 

Hold that number in your mind’s eye, and make a mantra of when it was used imperfectly. 

Better yet, hold your breath and meditate on this: if we wanted to. 

Do this, and you’ll know why I made “’THE KEY.’

8. 

HIV is the most stigmatized disease I know. 

Gay men are the most stigmatized people I know. 

There’s some sick poetry in this correlation between the two. It makes me hear Kurt Cobain singing: 

WITH THE LIGHTS OUT, IT’S LESS DANGEROUS 

These days, it’s my theme song. My mantra. 

In seven words, Nirvana captures a mindset and makes of it an epitaph to lay to rest the results of 30+ years of HIV prevention in the minds of gay men. 

That’s why I made ‘THE KEY.’

9. 

Miss Honey loves her Molotov cocktails, as much as she loves poppers and ass. 

I ran into her Monday night on the 3rd floor of Club Z, drunk off her ass again. We both had to piss, but she was the first one to pull out her cock and write a message on the carpet: 

THIS AIN’T NO MISS GAY TUSKEGEE PAGEANT 

SO FUCK YOUR VACCINE THAT MADE ME SUSCEPTIBLE 

AND GIVE ME PrEP 

I pissed myself laughing.  She then turned like a Queen back to her room with her cock still out and sang to all the cocksuckers: 

ONE DAY 

MY PRINCE 

WILL CUM! 

And that’s why I made ‘THE KEY.’ 

10. 

‘Smells Like Teen Spirit’ is the soundtrack to my sex life, and not because I live in Seattle. 

I meet guys at sex parties who freak out around any talk of HIV and assume if you bring it up that you have HIV. 

I meet guys online who choose sex partners through a terse tango we all quickly learn whose dance steps have accompanying lyrics which can be sung to the melody of “Hernando’s Hideaway:” 

“You clean?”

”Yeah. You?”

“Yeah. Wanna fuck?” 

I meet guys in bathhouses who slam meth and believe that olive oil used as lubricant will kill HIV. 

I meet these guys, and I hear in my head that guitar riff that launched Kurt into the stars with barely the chance to leave behind his letter to Boddah. 

I meet guys, and sometimes that riff becomes a chainsaw. 

And that’s why I made ‘THE KEY.’ 

11. 

You’d think that at least all the gay guys who work in The HIV Biz would be oversharing with all their friends and fuck buddies the good news about PrEP. 

You’d think at least they would be recommending it to their gay clients, supplying all the information they can find about PrEP, dreaming up ways for ALL OF US who can’t afford it to access it. 

With the good news about PrEP, you’d think we would at least be witnessing an orgy of activity on that mythic grassroots level. 

But none of the gay guys working in The HIV Biz here in Progressive Seattle seem to care much for oversharing, let alone recommending, supplying, or dreaming. 

That’s why I made ‘THE KEY.’ 

12. 

Here’s a little secret for you. 

Seattle often refers to herself as Progressive. 

It’s the adjective she’s been in An Open Relationship with for decades. 

You always see them hanging together in those declarative sentences that make our Starbucks warm havens for Microsoft employees. 

However, you should know that it’s not really An Open Relationship. 

Drop by for a drink after work at any of Seattle’s gay bars, and I’ll introduce you to some Queens who can tell you stories about Seattle, if you’ll buy them all a drink. 

Get them a little tipsy, and they can tell you tales of how she’s been stepping out on Progressive with other adjectives, including --but not limited to-- Complacent, Conservative, and Racist. 

And, believe me, these Queens should know. 

And that’s why I made  ‘THE KEY.’ 

13. 

My Candle in the Wind has blown out. 

That’s why I made ‘The Key.’ 

This video originally appeared on Jake Sobo’s blog  “The Time For Debate is Over. The Time to Implement PrEP is Now” here.

About Magpie Suddenly: 

A boy. A faggot. A poet. A singer. An actor. A director. A photographer.  A high school teacher.  A pot head.  A baker of bread. A disease intervention specialist. A videographer. A pornographer. A cashier. A tutor. A shoe salesmen to strippers and drag queens. A sex shop clerk. A partner. An HIV advocate. An amateur sex therapist. A community liaison. A boyfriend. A chair. A trick. An assistant artistic director. A drummer. A wounded healer. A fuck buddy. A faerie. A daddy. A man.

MarketPlace